All articles tagged with #peptides
RFK Jr., serving as HHS secretary, said on the Joe Rogan Experience that he plans to reverse the FDA’s 2023 ban on certain peptides, with about 14 of them set to be unbanned and made accessible through ethical suppliers in the coming weeks. The push comes despite limited human safety data and has sparked lawsuits and a debate over FDA authority vs. patient access to unapproved drugs.
An UnHerd piece examines the cultural fascination with peptide-based body enhancements and the potential health and societal consequences, questioning the long‑term effects of optimization, the costs to public health systems, and the social pressure to alter our bodies in pursuit of a hyper‑enhanced ideal.
Researchers tested IKVAV-PA, a peptide-based nanomaterial, in a mouse model of acute ischemic stroke and found that systemic delivery allows the molecules to cross the blood-brain barrier and reduce brain tissue damage, inflammation, and harmful immune responses after reperfusion, indicating potential as an adjunct therapy—though human safety and long-term efficacy remain to be studied.
The article discusses the widespread availability of Chinese peptide dealers, highlighting the growing accessibility and interest in peptides for health and supplement purposes.
The article explains that while topical collagen creams mainly hydrate and temporarily plump the skin, ingredients like vitamin C, peptides, and growth factors are more effective at stimulating collagen production for anti-aging benefits. It reviews the best collagen creams on the market, highlighting their key ingredients and suitable skin types, and emphasizes that consistent use and proper ingredient pairing are essential for visible results.
Researchers have developed peptide-based eye drops that target Toll-like receptor pathways to reverse vision loss caused by age-related macular degeneration, showing promising results in mouse models and offering a less invasive treatment option.
Peptides are emerging as a popular, low-cost alternative to traditional anti-ageing treatments among middle-aged men, touted for their ability to boost recovery, build muscle, and improve vitality. While some peptides have established medical uses, others are used off-label with potential risks, and experts advise consulting a doctor before use. The trend is partly driven by social media influence and a desire to maintain energy and youthfulness, with some high-profile advocates like Bryan Johnson exploring their potential.
The article discusses signs of collagen loss in skin and recommends products and ingredients, such as growth factors, retinol, peptides, and vitamin C, that can help slow this process and improve skin firmness and texture, emphasizing the importance of sun protection and a healthy lifestyle.
Peptides, such as GLP-1 receptor agonists, can be used for weight loss, with medications like Wegovy and Zepbound gaining attention. These peptides work by slowing stomach emptying and reducing cravings. FDA-approved options include semaglutide (Ozempic, Wegovy), tirzepetide (Mounjaro, Zepbound), and liraglutide (Saxenda), but it's important to consult a doctor before starting any weight loss regimen. Potential side effects include gastrointestinal issues, low blood sugar, and injection site reactions. Peptides for weight loss require a prescription and careful consideration of individual suitability and potential side effects.
Peptides like semaglutide and tirzepatide are gaining attention for their potential to aid in weight loss, with experts emphasizing that not all peptides are designed for this purpose. Peptides work by slowing down food movement through the gut and reducing cravings. FDA-approved options include semaglutide (Ozempic, Wegovy), tirzepetide (Mounjaro, Zepbound), and liraglutide (Saxenda), each with specific requirements and potential side effects. It's important to consult a doctor before considering peptide medications for weight loss, as they require a prescription and may have gastrointestinal side effects.
MIT neuroscientists have discovered a potential treatment for Alzheimer's disease using peptides that interact with the overactive CDK5 enzyme in Alzheimer's patients' brains. The treatment has undergone animal trials and shown promising results, reducing neurodegeneration and DNA damage in the brain, reducing mutations of Tau pathologies and neuron loss, and improving behavioral deficits. The peptide was also able to penetrate the blood-brain barrier and reach the neurons in the hippocampus. Further testing will be carried out to see which forms of dementia might benefit from this treatment.
Chemists from the University of Nebraska-Lincoln have discovered that the orientation of a single amino acid in a peptide can dictate the likelihood that the peptide activates one neuron receptor versus another. This finding points to another means by which a brain or nervous system can regulate the communication among its cells. The team discovered the phenomenon in a species of sea slug, but the findings should apply to a range of animals, potentially even humans. The discovery could open up new therapeutic avenues in terms of that specific target.
Researchers have developed a new class of peptides that could provide the benefits of gastric bypass surgery without the need for invasive procedures. These peptides contributed to significant weight loss and reduced blood glucose levels in rat models of obesity. The injectable compounds avoid the side effects of nausea and vomiting commonly experienced with current weight loss and diabetes drugs, and reduce eating while also increasing calorie burn. The researchers suggest that this may be due to GEP44 activating multiple receptors, which could prevent the intracellular signaling pathway that causes these symptoms.
Chemists at the University of Nebraska-Lincoln have discovered that the orientation of a single amino acid in a sea slug can determine which neuron receptor is activated, leading to different types of neuronal activities. This finding sheds light on how the brain can regulate communication between cells in different ways. The study reveals that the orientation of a single amino acid in a peptide can dictate the likelihood that the peptide activates one neuron receptor versus another, pointing to another means by which a brain or nervous system can regulate communication among its cells.